Provided by Tiger Trade Technology Pte. Ltd.

MSA Safety

182.67
-0.3800-0.21%
Volume:45.24K
Turnover:8.25M
Market Cap:7.08B
PE:25.72
High:183.59
Open:183.59
Low:179.88
Close:183.05
52wk High:208.92
52wk Low:127.86
Shares:38.77M
Float Shares:36.68M
Volume Ratio:0.61
T/O Rate:0.12%
Dividend:2.10
Dividend Rate:1.15%
EPS(TTM):7.10
EPS(LYR):7.09
ROE:22.22%
ROA:11.09%
PB:5.19
PE(LYR):25.76

Loading ...

Stock Track | MSA Safety Soars 5.08% Following Strong Q3 Earnings Report with $1.94 Adjusted EPS

Stock Track
·
Oct 29, 2025

Cloudastructure enters MSA with affordable housing developer

TIPRANKS
·
Oct 29, 2025

Cloudastructure Enters Master Services Agreement with Leading Affordable Housing Developer

GlobeNewswire
·
Oct 29, 2025

Tiziana Life Sciences to Present at BIO-Europe in Vienna, Highlighting Innovative Immunomodulation Therapy

GlobeNewswire
·
Oct 29, 2025

MSA Safety Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Oct 29, 2025

safety equipment provider MSA beats Q3 sales estimates, expects share buyback in Q4

Reuters
·
Oct 29, 2025

MSA Safety reports Q3 adjusted EPS $1.94, consensus $1.87

TIPRANKS
·
Oct 29, 2025

MSA Safety backs FY25 low-single-digit organic sales growth outlook

TIPRANKS
·
Oct 29, 2025

MSA Safety Reports Q3 Net Sales of $468 Million and Net Income of $70 Million

Reuters
·
Oct 29, 2025

BRIEF-MSA Safety Q3 Adjusted EPS USD 1.94 Vs. IBES Estimate USD 1.87

Reuters
·
Oct 29, 2025

MSA Safety Q3 EPS USD 1.77

THOMSON REUTERS
·
Oct 29, 2025

MSA Safety: Continuing to Manage Through U.S. Government Shutdown

THOMSON REUTERS
·
Oct 29, 2025

MSA Safety Inc - Maintains Low-Single-Digit Organic Sales Growth Outlook for 2025

THOMSON REUTERS
·
Oct 29, 2025

ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group

GlobeNewswire
·
Oct 22, 2025

MSA Safety Inc. to Announce Third Quarter 2025 Financial Results

Reuters
·
Oct 15, 2025

Alterity Therapeutics Presents Positive Data from ATH434 Phase 2 Trial at the 2025 International Congress of Parkinson’s Disease and Movement Disorders

GlobeNewswire
·
Oct 09, 2025

Should MSA Safety’s (MSA) Pacific-Asia Gateway Launch Prompt a Fresh Look at Its Digital Expansion?

Simply Wall St.
·
Oct 09, 2025

Why CoreWeave Stock Rocketed Higher in September

Motley Fool
·
Oct 03, 2025

Alterity Therapeutics to Deliver Multiple Presentations at the 2025 International Congress of Parkinson’s Disease and Movement Disorders

GlobeNewswire
·
Oct 02, 2025

Alterity Therapeutics to Present Promising Phase 2 Trial Results for MSA Treatment at 2025 Congress

TIPRANKS
·
Oct 02, 2025